{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:01:58Z","timestamp":1707523318309},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,18]]},"DOI":"10.7759\/cureus.40584","type":"journal-article","created":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T11:13:56Z","timestamp":1687086836000},"source":"Crossref","is-referenced-by-count":0,"title":["Murphy\u2019s Law and Ophthalmic Complications in a Patient With Type 1 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Zineb","family":"Barkhane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purnashree","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamedalamin Alnoor","family":"Altayb Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzeb","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_33_17","article-title":"Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia","volume":"65","author":"Al-Bahlal A","year":"2017","unstructured":"Al-Bahlal A, Khandekar R, Al Rubaie K, Alzahim T, Edward DP, Kozak I. Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia. Indian J Ophthalmol. 2017, 65:969-73. 10.4103\/ijo.IJO_33_17","journal-title":"Indian J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1971.tb00954.x","article-title":"The frequency of rubeosis iridis in diabetic patients","volume":"49","author":"Ohrt V","year":"1971","unstructured":"Ohrt V. The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol (Copenh). 1971, 49:301-7. 10.1111\/j.1755-3768.1971.tb00954.x","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e318259aec4","article-title":"Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma","volume":"22","author":"Mahdy RA","year":"2013","unstructured":"Mahdy RA, Nada WM, Fawzy KM, Alnashar HY, Almosalamy SM. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma. J Glaucoma. 2013, 22:768-72. 10.1097\/IJG.0b013e318259aec4","journal-title":"J Glaucoma"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/019262339902700507","article-title":"Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration","volume":"27","author":"Mordenti J","year":"1999","unstructured":"Mordenti J, Cuthbertson RA, Ferrara N, et al.. Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration. Toxicol Pathol. 1999, 27:536-44. 10.1177\/019262339902700507","journal-title":"Toxicol Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration","volume":"36","author":"Rosenfeld PJ","year":"2005","unstructured":"Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005, 36:331-5. 10.3928\/1542-8877-20050701-14","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.07.041","article-title":"Severe intraocular inflammation after intravitreal injection of bevacizumab","volume":"117","author":"Sato T","year":"2010","unstructured":"Sato T, Emi K, Ikeda T, et al.. Severe intraocular inflammation after intravitreal injection of bevacizumab. Ophthalmology. 2010, 117:512-6, 516.e1-2. 10.1016\/j.ophtha.2009.07.041","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.01067.x","article-title":"Complications in patients after intravitreal injection of bevacizumab","volume":"86","author":"Shima C","year":"2008","unstructured":"Shima C, Sakaguchi H, Gomi F, et al.. Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol. 2008, 86:372-6. 10.1111\/j.1600-0420.2007.01067.x","journal-title":"Acta Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-016-0051-x","article-title":"Neovascular glaucoma: a review","volume":"2","author":"Rodrigues GB","year":"2016","unstructured":"Rodrigues GB, Abe RY, Zangalli C, et al.. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016, 2:26. 10.1186\/s40942-016-0051-x","journal-title":"Int J Retina Vitreous"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2019.01.009","article-title":"Toxic anterior segment syndrome: a review","volume":"64","author":"Hernandez-Bogantes E","year":"2019","unstructured":"Hernandez-Bogantes E, Navas A, Naranjo A, Amescua G, Graue-Hernandez EO, Flynn HW Jr, Ahmed I. Toxic anterior segment syndrome: a review. Surv Ophthalmol. 2019, 64:463-76. 10.1016\/j.survophthal.2019.01.009","journal-title":"Surv Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2010.01.030","article-title":"Toxic anterior segment syndrome: common causes","volume":"36","author":"Cutler Peck CM","year":"2010","unstructured":"Cutler Peck CM, Brubaker J, Clouser S, Danford C, Edelhauser HE, Mamalis N. Toxic anterior segment syndrome: common causes. J Cataract Refract Surg. 2010, 36:1073-80. 10.1016\/j.jcrs.2010.01.030","journal-title":"J Cataract Refract Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.98712","article-title":"Managing bevacizumab-induced intraocular inflammation","volume":"60","author":"Sinha S","year":"2012","unstructured":"Sinha S, Vashisht N, Venkatesh P, Garg SP. Managing bevacizumab-induced intraocular inflammation. Indian J Ophthalmol. 2012, 60:311-3. 10.4103\/0301-4738.98712","journal-title":"Indian J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181bd2d51","article-title":"Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch","volume":"30","author":"Yamashiro K","year":"2010","unstructured":"Yamashiro K, Tsujikawa A, Miyamoto K, et al.. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch. Retina. 2010, 30:485-90. 10.1097\/IAE.0b013e3181bd2d51","journal-title":"Retina"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2014.01.004","article-title":"Toxic anterior segment syndrome - a sequel of uneventful cataract surgery","volume":"71","author":"Moulick PS","year":"2015","unstructured":"Moulick PS, Reddy S, Gurunadh VS, Mohindra VK. Toxic anterior segment syndrome - a sequel of uneventful cataract surgery. Med J Armed Forces India. 2015, 71:S205-7. 10.1016\/j.mjafi.2014.01.004","journal-title":"Med J Armed Forces India"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/161916-murphys-law-and-ophthalmic-complications-in-a-patient-with-type-1-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:20Z","timestamp":1707508160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/161916-murphys-law-and-ophthalmic-complications-in-a-patient-with-type-1-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,18]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.40584","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,18]]}}}